Publications
109
Citations
1,345
Est. group size
—
Recurring co-author estimate
Active years
54
Publishing since 1973
Peter H. Schwartz works at the intersection of medical ethics and clinical decision-making, studying how patients understand medical information and give informed consent. A recurring focus is colorectal cancer screening, including how personalized risk information and decision aids affect whether and how patients choose to be screened. He also examines ethical questions around research consent, biobanks, and patient privacy.
Publication activity has been steady over the past decade, averaging around four to five papers per year with a peak in 2024.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Typically publishes in teams of ~4 · 46% small-team papers (≤3 authors) · across 24 venues
- Asking Patients on Principle: Public Deliberation About Waiver or Modification of Consent
The American Journal of Bioethics · 2026
- Considering Personal Utility in Assessments of Medical Interventions: The Case of Lung Cancer Screening
The American Journal of Bioethics · 2026
- Effect of Personalized Risk Messages on Uptake of Colorectal Cancer Screening
Annals of Internal Medicine · 2025
- Statins Do Not Affect Bone Anabolism in Older Women Treated With Teriparatide
The Journal of Clinical Endocrinology & Metabolism · 2025
- Informed Consent and Comprehension after the Pragmatic Turn
The American Journal of Bioethics · 2025
- Returning Clinically Relevant Research Results to Participants: Guidelines for Investigators and the IRB
Ethics & Human Research · 2024
- Discordant Care and Decision Quality: Patients’ Reasons for Not Receiving Their Initial Test of Choice in Colorectal Cancer Screening
Medical Decision Making · 2024
- Patient Navigation Plus Tailored Digital Video Disc Increases Colorectal Cancer Screening Among Low-Income and Minority Patients Who Did Not Attend a Scheduled Screening Colonoscopy: A Randomized Trial
Annals of Behavioral Medicine · 2024
- Defining and Defending Personhood: Lessons from the Disease Debate
The American Journal of Bioethics · 2024
- Selling Clinical Biospecimens: Guidance for Researchers and Private Industry
The Journal of Law Medicine & Ethics · 2023
- P35 Two-year clinical outcomes with fordadistrogene movaparvovec (FM) for Duchenne muscular dystrophy (DMD) and contextualization with external controls
Neuromuscular Disorders · 2023
- Reaching Ambulatory Older Adults with Educational Tools: Comparative Efficacy and Cost of Varied Outreach Modalities in Primary Care
Journal of General Internal Medicine · 2022
- Measuring the Impact of Quantitative Information on Patient Understanding: Approaches for Assessing the Adequacy of Patient Knowledge about Colorectal Cancer Screening
MDM Policy & Practice · 2022
- Rethinking Decision Quality: Measures, Meaning, and Bioethics
The Hastings Center Report · 2022
- Development of a Computer-Tailored Intervention/Decision Aid To Increase Colorectal Cancer Screening in Health Systems
Cureus · 2022
- The American Journal of Bioethics×6
- Medical Decision Making×5
- Ethics & Human Research×3
- The Hastings Center Report×3
- Author eBooks×3
- Scott Y. H. Kim
Medicine · University of Michigan
- Kayte Spector‐Bagdady
Medicine · University of Michigan
- Deneil Harney
Medicine · University of Michigan
- Naomi Scheinerman
Medicine · The Ohio State University
- Sarah Van Heiden
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile